Core Viewpoint - Duople is a leading enterprise in the domestic ultrasonic phased array testing equipment sector, demonstrating strong profitability and growth potential in the non-destructive testing industry [1] Company Performance - In H1 2025, the company achieved revenue of 80 million yuan, representing a year-on-year growth of 56.2% [1] - The net profit attributable to the parent company reached 20 million yuan, with a year-on-year increase of 12.15% [1] - The company's gross profit margin has maintained above 70% from 2020 to 2024, positioning it at the upstream of the industry [1] Industry Outlook - The non-destructive testing industry is rapidly developing, with significant potential for domestic substitution of imports [1] - The establishment of industry standards is driving demand for the replacement of testing methods, opening up growth opportunities for phased array testing [1] - The company's strong technical barriers and the expansion of medical and automation demands are expected to create a second growth point for the company [1] Investment Rating - The company is rated as a "buy" based on its strong technology and profitability, along with the broad market space in non-destructive testing, indicating expectations for sustained stable growth in performance [1]
研报掘金丨国盛证券：多浦乐盈利能力优异，维持“买入”评级